initial public offerings (IPOs) trading on American exchanges

Friday, June 5, 2015

EndoChoice (GI) began trading on the NYSE on 5 June 2015

  • EndoChoice Holdings (NYSE:GI) priced at 15, the low end of its estimated range. It raised $95 million by offering 6.35 million shares. 
  • The medical device company makes endoscopic imaging systems with wide field-of-view cameras, devices and infection control products and pathology services for treating a wide range of gastrointestinal conditions, including colon cancer. 
  • EndoChoice’s revenues have nearly doubled in the past three years, from $34 million in 2012 to $61.4 million in 2014. The company has yet to produce a profit, posting losses of $1.2 million, $25.5 million and $52.7 million for 2012, 2013 and 2014, respectively.
  • EndoChoice is led by Mark Gilreath, 49, who founded the company in 2007.
ticker: GI

EndoChoice founder and CEO Mark Gilreath.

No comments:

Post a Comment